EUVIMEDEUVIMED entdecken
Crossref

Radiotherapy Outcomes and Prognostic Factors in Head and Neck NUT Carcinoma: A Single‐Center Cohort Analysis

Zhuomiao Ye iD, Helei Yan, Xin Li iD, Dan Yang, Fei Xie, Chao Deng, Mingzhu Yin iD

Head & Neck · 2026-04 · 48 (4) · 975-985

DOI: 10.1002/hed.70119 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Head & Neck, online erschienen am 02.12.2025. Verfasst von Zhuomiao Ye und 6 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Research Center (CRC), Chongqing University Three Gorges Hospital, Chongqing University, Chongqing, China. Hauptthemen laut MEDLINE: Head and Neck Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Gefördert von: the Science and Technology Innovation Key R&D Program of Chongqing, Fundamental Research Funds for the Central Universities, Chongqing Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

NUT carcinoma is a rare, aggressive malignancy defined by NUTM1 gene rearrangement, with the head and neck as the second most common site. Its prognosis is poor, and current treatment references other cancers. Although radiotherapy is key in managing head and neck tumors, its efficacy and prognostic factors in head and neck NUT carcinoma are unclear.

Methods

We retrospectively analyzed 31 patients with locally advanced or recurrent/metastatic head and neck NUT carcinoma treated with radiotherapy. OS and PFS were estimated by Kaplan–Meier, and prognostic factors were identified using Cox regression.

Results

Among 31 patients (64.5% male, median age 37), nasal cavity/paranasal sinuses were the most common primary site (51.6%). Most received intensity‐modulated radiotherapy with ≥ 66 Gy. Median OS and PFS were 18.73 and 3 months, respectively. Nasal cavity/paranasal sinus primaries had the worst prognosis (median OS: 16.7 months). Locally advanced cases had significantly better survival than recurrent/metastatic disease (median OS: 30.43 vs. 13.93 months; PFS: 5.83 vs. 2.3 months). High‐dose radiotherapy (≥ 66 Gy) was associated with improved OS, and R0 resection combined with ≥ 66 Gy achieved median OS of 27.9 months. In surgical patients, GTV longest diameter > 3.5 cm independently predicted worse PFS (HR = 5.01, p = 0.01). Recurrent/metastatic status was the most critical independent adverse prognostic factor for both PFS (HR = 4.56) and OS (HR = 10.12). Adjuvant therapy after radiotherapy prolonged PFS, particularly in locally advanced patients. BETi‐based regimens before radiotherapy showed potential for improved locoregional and distant control in postoperative recurrence/metastasis.

Conclusions

Prognosis in head and neck NUT carcinoma treated with radiotherapy is affected by disease status, primary site, radiotherapy dose, and adjuvant therapy. Locally advanced patients benefit most from high‐dose radiotherapy and adjuvant therapy. GTV > 3.5 cm identifies high‐risk populations requiring intensified treatment, while BETi may improve outcomes in postoperative recurrence/metastasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Head and Neck NeoplasmsHumansMaleFemaleRetrospective StudiesMiddle AgedAdultPrognosisNeoplasm Recurrence, LocalRadiotherapy, Intensity-ModulatedAgedTreatment OutcomeKaplan-Meier EstimateCohort StudiesYoung AdultRadiotherapy DosageNeoplasm ProteinsNuclear Proteins

Stichwörter der Autor:innen

NUT carcinomaNUTM1cohortradiotherapy

Substanzen

NUTM1 protein, humanNeoplasm ProteinsNuclear Proteins

Autor:innen und Institutionen

  • Clinical Research Center (CRC), Chongqing University Three Gorges Hospital, Chongqing University, Chongqing, China.
  • Medical Pathology Center (MPC), Chongqing University Three Gorges Hospital, Chongqing University, Chongqing, China.
  • Institute of Advanced Interdisciplinary Studies, Chongqing University, Chongqing, China.
  • CQU-Ferenc Krausz Nobel Laureate Scientific Workstation, Chongqing University Three Gorges Hospital & Academy for Advanced Interdisciplinary Technology, Chongqing, China.
  • Cancer Early Detection and Treatment Center (CEDTC), Chongqing University Three Gorges Hospital, Chongqing University, Chongqing, China.
  • Department of Breast Surgery, Chongqing University Three Gorges Hospital, Chongqing University, Chongqing, China.

ORCID-Profile: Zhuomiao Ye, Xin Li, Mingzhu Yin

Förderung

  • the Science and Technology Innovation Key R&D Program of Chongqing
  • Fundamental Research Funds for the Central Universities
  • Chongqing Natural Science Foundation
  • The Natural Science Foundation of Chongqing
  • Natural Science Foundation of Chongqing Municipality

Zitieren

APA

Ye, Z., Yan, H., Li, X., Yang, D., Xie, F., Deng, C., & Yin, M. (2026). Radiotherapy Outcomes and Prognostic Factors in Head and Neck NUT Carcinoma: A Single‐Center Cohort Analysis. Head & Neck, 48(4), 975-985. https://doi.org/10.1002/hed.70119

Vancouver

Ye Z, Yan H, Li X, Yang D, Xie F, Deng C, et al. Radiotherapy Outcomes and Prognostic Factors in Head and Neck NUT Carcinoma: A Single‐Center Cohort Analysis. Head & Neck. 2026;48(4):975-985. doi:10.1002/hed.70119

BibTeX
@article{Ye2026,
  author = {Ye, Zhuomiao and Yan, Helei and Li, Xin and Yang, Dan and Xie, Fei and Deng, Chao and Yin, Mingzhu},
  title = {Radiotherapy Outcomes and Prognostic Factors in Head and Neck NUT Carcinoma: A Single‐Center Cohort Analysis},
  journal = {Head & Neck},
  year = {2026},
  volume = {48},
  number = {4},
  pages = {975--985},
  doi = {10.1002/hed.70119}
}
Kostenlos starten →